金迪克2025年首批流感疫苗批签发予以签发

Core Viewpoint - The China Food and Drug Administration has approved the first batch of the quadrivalent influenza vaccine from Jindike for 2025 [1] Company Summary - Jindike's quadrivalent influenza vaccine has received regulatory approval, indicating progress in the company's vaccine development efforts [1] Industry Summary - The approval of the influenza vaccine reflects ongoing advancements in the pharmaceutical industry, particularly in vaccine development and public health initiatives [1]